메뉴 건너뛰기




Volumn 8, Issue 3, 2013, Pages

An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel Syndrome

Author keywords

[No Author keywords available]

Indexed keywords

1 PROPANOL 2 METHYL; ALDEHYDE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; ESTER DERIVATIVE; FATTY ACID ESTER; KETONE; METHOXYPHENYL OXIME; ORGANIC COMPOUND; UNCLASSIFIED DRUG; UNDECANE; VOLATILE ORGANIC COMPOUND;

EID: 84874828665     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058204     Document Type: Article
Times cited : (132)

References (57)
  • 1
    • 0033673642 scopus 로고    scopus 로고
    • British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome
    • Jones J, Boorman J, Cann P, Forbes A, Gornborone J, et al. (2000) British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. GUT 47: 1-19.
    • (2000) GUT , vol.47 , pp. 1-19
    • Jones, J.1    Boorman, J.2    Cann, P.3    Forbes, A.4    Gornborone, J.5
  • 2
    • 38449100398 scopus 로고    scopus 로고
    • Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence
    • Williams JG, Roberts SE, Ali MF, Cheung WY, Cohen DR, et al. (2007) Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. GUT 56: 1-113.
    • (2007) GUT , vol.56 , pp. 1-113
    • Williams, J.G.1    Roberts, S.E.2    Ali, M.F.3    Cheung, W.Y.4    Cohen, D.R.5
  • 3
    • 0025353812 scopus 로고
    • Epidemiology of irritable bowel syndrome in the United States
    • Sandler RS, (1990) Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 99: 409-15.
    • (1990) Gastroenterology , vol.99 , pp. 409-415
    • Sandler, R.S.1
  • 6
    • 1942470635 scopus 로고    scopus 로고
    • Irritable bowel syndrome: a model of the brain-gut interactions
    • Mulak A, (2004) Irritable bowel syndrome: a model of the brain-gut interactions. Med Sci Monit 10(4): 55-62.
    • (2004) Med Sci Monit , vol.10 , Issue.4 , pp. 55-62
    • Mulak, A.1
  • 8
    • 15744395134 scopus 로고    scopus 로고
    • A prospective assessment of bowel habit in irritable bowel syndrome in women: Defining an alternator
    • Drossman DA, Morris CB, Hu Y, Toner BB, Diamant N, et al. (2005) A prospective assessment of bowel habit in irritable bowel syndrome in women: Defining an alternator. Gastroenterology 28: 580-9.
    • (2005) Gastroenterology , vol.28 , pp. 580-589
    • Drossman, D.A.1    Morris, C.B.2    Hu, Y.3    Toner, B.B.4    Diamant, N.5
  • 10
    • 77950519352 scopus 로고    scopus 로고
    • Validation of symptom-based diagnostic criteria for irritable bowel syndrome: A critical review
    • Whitehead WE, Drossman DA, (2006) Validation of symptom-based diagnostic criteria for irritable bowel syndrome: A critical review. Am J Gastroenterol 105: 814-820.
    • (2006) Am J Gastroenterol , vol.105 , pp. 814-820
    • Whitehead, W.E.1    Drossman, D.A.2
  • 12
    • 28944446372 scopus 로고    scopus 로고
    • Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases?
    • Eamonn MMQ (2005) Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases? Chinese J of Digestive Dis. 122-32.
    • (2005) Chinese J of Digestive Dis. , pp. 122-132
    • Eamonn, M.M.Q.1
  • 13
    • 10644257329 scopus 로고    scopus 로고
    • Review article: epidemiology and quality of life in functional gastrointestinal disorders
    • Change L, (2004) Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 20: 31-9.
    • (2004) Aliment Pharmacol Ther , vol.20 , pp. 31-39
    • Change, L.1
  • 16
    • 0036320081 scopus 로고    scopus 로고
    • Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease
    • Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I, (2002) Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 123: 450-60.
    • (2002) Gastroenterology , vol.123 , pp. 450-460
    • Tibble, J.A.1    Sigthorsson, G.2    Foster, R.3    Forgacs, I.4    Bjarnason, I.5
  • 17
    • 38849194737 scopus 로고    scopus 로고
    • Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies
    • Schoepfer AM, Trummler M, Seeholzer P, Criblez DH, Seibold F, (2008) Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflamm Bowel Dis 14: 32-9.
    • (2008) Inflamm Bowel Dis , vol.14 , pp. 32-39
    • Schoepfer, A.M.1    Trummler, M.2    Seeholzer, P.3    Criblez, D.H.4    Seibold, F.5
  • 18
    • 51849157847 scopus 로고    scopus 로고
    • Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome
    • Otten CM, Kok L, Witteman BJ, Baumgarten R, Kampman E, et al. (2008) Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome. Clin Chem Lab Med 46: 1275-80.
    • (2008) Clin Chem Lab Med , vol.46 , pp. 1275-1280
    • Otten, C.M.1    Kok, L.2    Witteman, B.J.3    Baumgarten, R.4    Kampman, E.5
  • 19
    • 17144363641 scopus 로고    scopus 로고
    • Faecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome
    • Silberer H, Kuppers B, Mickisch O, Baniewicz W, Drescher M, et al. (2005) Faecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome. Clin Lab 51: 117-26.
    • (2005) Clin Lab , vol.51 , pp. 117-126
    • Silberer, H.1    Kuppers, B.2    Mickisch, O.3    Baniewicz, W.4    Drescher, M.5
  • 21
    • 0347722496 scopus 로고    scopus 로고
    • A novel method for rapidly diagnosing the causes of diarrhoea
    • Probert CSJ, Jones PRH, Ratcliffe NM, (2004) A novel method for rapidly diagnosing the causes of diarrhoea. GUT 53: 58-61.
    • (2004) GUT , vol.53 , pp. 58-61
    • Probert, C.S.J.1    Jones, P.R.H.2    Ratcliffe, N.M.3
  • 22
    • 79954530529 scopus 로고    scopus 로고
    • Solid-phase microextraction and the human fecal VOC metabolome
    • Dixon E, Clubb C, Pittman S, Ammann L, Rasheed Z, et al. (2011) Solid-phase microextraction and the human fecal VOC metabolome. PLoS ONE 6(4): e18471.
    • (2011) PLoS ONE , vol.6 , Issue.4
    • Dixon, E.1    Clubb, C.2    Pittman, S.3    Ammann, L.4    Rasheed, Z.5
  • 23
    • 79955618774 scopus 로고    scopus 로고
    • Impact of the synbiotic combination of Lactulose casei shirota and oligofructose-enriched inulin on the fecal volatile metabolite profile in the healthy subjects
    • De Preter V, Ghebretinsea AH, Abrahantes JC, Windey K, Rutgeerts P, et al. (2011) Impact of the synbiotic combination of Lactulose casei shirota and oligofructose-enriched inulin on the fecal volatile metabolite profile in the healthy subjects. Mol Nutr Food Res 55(5): 714-22.
    • (2011) Mol Nutr Food Res , vol.55 , Issue.5 , pp. 714-722
    • De Preter, V.1    Ghebretinsea, A.H.2    Abrahantes, J.C.3    Windey, K.4    Rutgeerts, P.5
  • 24
    • 34249816158 scopus 로고    scopus 로고
    • Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease
    • Garner CE, Smith S, de Lacy Costello B, White P, Spencer R, et al. (2007) Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J 21: 1675-88.
    • (2007) FASEB J , vol.21 , pp. 1675-1688
    • Garner, C.E.1    Smith, S.2    de Lacy Costello, B.3    White, P.4    Spencer, R.5
  • 25
    • 70350635540 scopus 로고    scopus 로고
    • Analysis of fecal volatile organic compounds in preterm infants who develop necrotising enterocolitis: a pilot study
    • Garner CE, Ewer AK, Elasouad K, Power F, Greenwood R, et al. (2009) Analysis of fecal volatile organic compounds in preterm infants who develop necrotising enterocolitis: a pilot study. J Pediatr Gastroenterol Nutr 49: 559-65.
    • (2009) J Pediatr Gastroenterol Nutr , vol.49 , pp. 559-565
    • Garner, C.E.1    Ewer, A.K.2    Elasouad, K.3    Power, F.4    Greenwood, R.5
  • 27
    • 0019319257 scopus 로고
    • A simple index of Crohn's disease activity
    • Harvey RF, Bradshaw JM, (1980) A simple index of Crohn's disease activity. The Lancet 315: 514-6.
    • (1980) The Lancet , vol.315 , pp. 514-516
    • Harvey, R.F.1    Bradshaw, J.M.2
  • 28
    • 0029047515 scopus 로고
    • Evaluation of disease activity in patients with moderately active ulcerative colitis: comparisons between a new activity index and Truelove and Witts' classification
    • Seo M, Okada M, Yao T, Okabe N, Maeda K, et al. (1995) Evaluation of disease activity in patients with moderately active ulcerative colitis: comparisons between a new activity index and Truelove and Witts' classification. Am J Gastroenterol 90(10): 1759-63.
    • (1995) Am J Gastroenterol , vol.90 , Issue.10 , pp. 1759-1763
    • Seo, M.1    Okada, M.2    Yao, T.3    Okabe, N.4    Maeda, K.5
  • 30
    • 0000859675 scopus 로고
    • An asymptotic equivalence of choice of model by cross-validation and Akaike's criterion
    • Stone M, (1977) An asymptotic equivalence of choice of model by cross-validation and Akaike's criterion. Journal of the Royal Statistical Society Series B (Methodological) 39: 44-7.
    • (1977) Journal of the Royal Statistical Society Series B (Methodological) , vol.39 , pp. 44-47
    • Stone, M.1
  • 31
    • 75349109603 scopus 로고    scopus 로고
    • Elevated pro-inflammatory and Lipotoxic mucosal lipids chracterise irritable bowel syndrome
    • Kajander K, Myllyluoma E, Kyronpalo S, Rasmussen M, Sipponen P, et al. (2009) Elevated pro-inflammatory and Lipotoxic mucosal lipids chracterise irritable bowel syndrome. World J Gasteroenterol 14: 6068-74.
    • (2009) World J Gasteroenterol , vol.14 , pp. 6068-6074
    • Kajander, K.1    Myllyluoma, E.2    Kyronpalo, S.3    Rasmussen, M.4    Sipponen, P.5
  • 32
    • 77950670562 scopus 로고    scopus 로고
    • Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome
    • Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, et al. (2010) Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterology & Motility 22(5): 512-9.
    • (2010) Neurogastroenterology & Motility , vol.22 , Issue.5 , pp. 512-519
    • Tana, C.1    Umesaki, Y.2    Imaoka, A.3    Handa, T.4    Kanazawa, M.5
  • 33
    • 0018816521 scopus 로고
    • Degradation of organic acids by dairy lactic acid bacteria
    • Hegazi FZ Abo-EInaga IG, (1980) Degradation of organic acids by dairy lactic acid bacteria. Zentralbl Bakteriol Naturwiss 135(3): 212-22.
    • (1980) Zentralbl Bakteriol Naturwiss , vol.135 , Issue.3 , pp. 212-222
    • Hegazi, F.Z.1    Abo-EInaga, I.G.2
  • 34
    • 0031453130 scopus 로고    scopus 로고
    • Comparison of batch culture growth and fermentation of a poultry veillonella isolate and selected veillonella species grown in a defined medium
    • Durant JA, Nisbet DJ, Ricke SC, (1997) Comparison of batch culture growth and fermentation of a poultry veillonella isolate and selected veillonella species grown in a defined medium. Anaerobe 3: 391-7.
    • (1997) Anaerobe , vol.3 , pp. 391-397
    • Durant, J.A.1    Nisbet, D.J.2    Ricke, S.C.3
  • 35
    • 84872754649 scopus 로고    scopus 로고
    • High-level dietary fibre up-regulates colonic fermentation and relative abundance of saccharolytic bacteria within the human faecal microbiota in vitro
    • Shen Q, Zhao L, Tuohy K, (2011) High-level dietary fibre up-regulates colonic fermentation and relative abundance of saccharolytic bacteria within the human faecal microbiota in vitro. European Journal of Nutrition pp. 1-13.
    • (2011) European Journal of Nutrition , pp. 1-13
    • Shen, Q.1    Zhao, L.2    Tuohy, K.3
  • 36
    • 7244231035 scopus 로고    scopus 로고
    • Inhibitory actions of a high fibre diet on intestinal gas transit in healthy volunteers
    • Gonlachanvit S, Coleski R, Owyang C, Hasler W, (2004) Inhibitory actions of a high fibre diet on intestinal gas transit in healthy volunteers. GUT 53(11): 1577-82.
    • (2004) GUT , vol.53 , Issue.11 , pp. 1577-1582
    • Gonlachanvit, S.1    Coleski, R.2    Owyang, C.3    Hasler, W.4
  • 37
    • 37149033981 scopus 로고    scopus 로고
    • Systematic review and meta-analysis: the clinical and physiological effects of fibre-containing enteral formulae
    • Elia M, Engfer MB, Green CJ, Silk DB, (2008) Systematic review and meta-analysis: the clinical and physiological effects of fibre-containing enteral formulae. Aliment Pharmacol Ther 27: 120-45.
    • (2008) Aliment Pharmacol Ther , vol.27 , pp. 120-145
    • Elia, M.1    Engfer, M.B.2    Green, C.J.3    Silk, D.B.4
  • 38
    • 0030731874 scopus 로고    scopus 로고
    • Absence of gaseous symptoms during ingestion of commercial fibre preparations
    • Zumarraga L, Suarez F, (1997) Absence of gaseous symptoms during ingestion of commercial fibre preparations. Aliment Pharmacol Ther 11: 1067-72.
    • (1997) Aliment Pharmacol Ther , vol.11 , pp. 1067-1072
    • Zumarraga, L.1    Suarez, F.2
  • 39
    • 80054983182 scopus 로고    scopus 로고
    • Comparison of symptom response following advice for a diet low in fermentable (FODMAP) carbohydrates versus standard dietary advice in patients with IBS
    • Staudacher HM, Whelan K, Irving PM, Lorner MC, (2011) Comparison of symptom response following advice for a diet low in fermentable (FODMAP) carbohydrates versus standard dietary advice in patients with IBS. J Hum Nutr Diet 24(5): 487-95.
    • (2011) J Hum Nutr Diet , vol.24 , Issue.5 , pp. 487-495
    • Staudacher, H.M.1    Whelan, K.2    Irving, P.M.3    Lorner, M.C.4
  • 40
    • 77954907393 scopus 로고    scopus 로고
    • Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in IBS
    • Ong DK, Mitchell SB, Barrett JS, Shepherd SJ, Irving PM, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in IBS. J Gastroenterol Hepatol 25(8): 1366-73.
    • J Gastroenterol Hepatol , vol.25 , Issue.8 , pp. 1366-1373
    • Ong, D.K.1    Mitchell, S.B.2    Barrett, J.S.3    Shepherd, S.J.4    Irving, P.M.5
  • 41
    • 77649299288 scopus 로고    scopus 로고
    • Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?
    • Reddymasu S, Sostarich S, McCallum R, (2010) Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors? BMC Gastroenterology 10: 23.
    • (2010) BMC Gastroenterology , vol.10 , pp. 23
    • Reddymasu, S.1    Sostarich, S.2    McCallum, R.3
  • 42
    • 0037286459 scopus 로고    scopus 로고
    • Methane production during lactulose breath test is associated with gastrointestinal disease presentation
    • Pimentel M, Mayer A, Park S, Chow EJ, Hasan A, et al. (2003) Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci 48: 86-92.
    • (2003) Dig Dis Sci , vol.48 , pp. 86-92
    • Pimentel, M.1    Mayer, A.2    Park, S.3    Chow, E.J.4    Hasan, A.5
  • 43
    • 84863425462 scopus 로고    scopus 로고
    • Reassessment of the role of methane production between irritable bowel syndrome and functional constipation
    • Furnari M, Savarino V, Bruzzone L, Moscatelli A, Gemignani L, et al. (2012) Reassessment of the role of methane production between irritable bowel syndrome and functional constipation. J Gastrointestin Liver Dis 21: 157-63.
    • (2012) J Gastrointestin Liver Dis , vol.21 , pp. 157-163
    • Furnari, M.1    Savarino, V.2    Bruzzone, L.3    Moscatelli, A.4    Gemignani, L.5
  • 46
    • 33745262396 scopus 로고    scopus 로고
    • Role of faecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease
    • Konikoff MR, Denson LA, (2006) Role of faecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis 12: 524-34.
    • (2006) Inflamm Bowel Dis , vol.12 , pp. 524-534
    • Konikoff, M.R.1    Denson, L.A.2
  • 47
    • 57449085396 scopus 로고    scopus 로고
    • Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease
    • Gisbert JP, McNicholl AG, (2009) Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Digestive and Liver Disease 41: 56-66.
    • (2009) Digestive and Liver Disease , vol.41 , pp. 56-66
    • Gisbert, J.P.1    McNicholl, A.G.2
  • 50
    • 14544308315 scopus 로고    scopus 로고
    • Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease
    • Costa F, Mumolo MG, Ceccarelli L, Bellini M, Romano MR, et al. (2005) Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. GUT 54(3): 364-8.
    • (2005) GUT , vol.54 , Issue.3 , pp. 364-368
    • Costa, F.1    Mumolo, M.G.2    Ceccarelli, L.3    Bellini, M.4    Romano, M.R.5
  • 51
    • 84859635560 scopus 로고    scopus 로고
    • Faecal markers: calprotectin and lactoferrin
    • Abraham BP, (2012) Faecal markers: calprotectin and lactoferrin. Gastroenterol Clin North Am 41: 483-95.
    • (2012) Gastroenterol Clin North Am , vol.41 , pp. 483-495
    • Abraham, B.P.1
  • 52
    • 33750480850 scopus 로고    scopus 로고
    • Metabolic profiling technologies for biomarker discovery in biomedicine and drug development
    • Schlotterbeck G, Ross A, Dieterle F, Senn H, (2006) Metabolic profiling technologies for biomarker discovery in biomedicine and drug development. Pharmacogenomics 7: 1055-75.
    • (2006) Pharmacogenomics , vol.7 , pp. 1055-1075
    • Schlotterbeck, G.1    Ross, A.2    Dieterle, F.3    Senn, H.4
  • 53
    • 42649087443 scopus 로고    scopus 로고
    • Investigation of volatile biomarkers in liver cancer blood using solid-phase microextraction and gas chromatography/mass spectrometry
    • Xue R, Dong L, Zhang S, Deng C, Liu T, et al. (2008) Investigation of volatile biomarkers in liver cancer blood using solid-phase microextraction and gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 22: 1181-6.
    • (2008) Rapid Commun Mass Spectrom , vol.22 , pp. 1181-1186
    • Xue, R.1    Dong, L.2    Zhang, S.3    Deng, C.4    Liu, T.5
  • 56
    • 73949103289 scopus 로고    scopus 로고
    • Volatile organic compounds in the diagnosis of gastrointestinal and liver disease. J Gastrointestin Liver Dis
    • Probert CS. Ahmed I, Khalid T, Johnson E, Smith S, et al. (2009) Volatile organic compounds in the diagnosis of gastrointestinal and liver disease. J Gastrointestin Liver Dis. 18(3): 337-43.
    • (2009) , vol.18 , Issue.3 , pp. 337-343
    • Probert, C.S.1    Ahmed, I.2    Khalid, T.3    Johnson, E.4    Smith, S.5
  • 57
    • 33746819836 scopus 로고    scopus 로고
    • Metabolomic approaches to phenotype characterization and application to complex disease
    • Oresic M, Vidal-Puig A, Hanninen V, (2006) Metabolomic approaches to phenotype characterization and application to complex disease. Expert review of molecular diagnostics 6: 575-85.
    • (2006) Expert Review of Molecular Diagnostics , vol.6 , pp. 575-585
    • Oresic, M.1    Vidal-Puig, A.2    Hanninen, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.